Growth Metrics

Zimmer Biomet Holdings (ZBH) Income from Continuing Operations (2016 - 2026)

Zimmer Biomet Holdings has reported Income from Continuing Operations over the past 18 years, most recently at 238300000.0 for Q1 2026.

  • For Q1 2026, Income from Continuing Operations rose 30.58% year-over-year to 238300000.0; the TTM value through Mar 2026 reached 888300000.0, up 33.96%, while the annual FY2025 figure was 832600000.0, 27.43% up from the prior year.
  • Income from Continuing Operations for Q1 2026 was 238300000.0 at Zimmer Biomet Holdings, down from 265400000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 419700000.0 in Q4 2023 and troughed at 11700000.0 in Q4 2024.
  • A 5-year average of 193111764.71 and a median of 194200000.0 in 2022 define the central range for Income from Continuing Operations.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 102.79% in 2024 and later surged 2368.38% in 2025.
  • Year by year, Income from Continuing Operations stood at 112200000.0 in 2022, then surged by 274.06% to 419700000.0 in 2023, then plummeted by 102.79% to 11700000.0 in 2024, then surged by 2368.38% to 265400000.0 in 2025, then dropped by 10.21% to 238300000.0 in 2026.
  • Business Quant data shows Income from Continuing Operations for ZBH at 238300000.0 in Q1 2026, 265400000.0 in Q4 2025, and 231200000.0 in Q3 2025.